These extensive, global, multi-year studies were designed to rigorously assess whether oral semaglutide could decelerate the progression of early stage symptomatic AD in over 3,800 participants (Scheltens et al., 2026)
Sold as Mounjaro (for diabetes) and Zepbound (for weight management), tirzepatide has quickly become the most prescribed alternative for people who want more weight loss than semaglutide delivers
Like other GLP-1 medications, Mounjaro has been prescribed to both diabetes patients and weight loss patients, but lawsuits claim that many suffered severe side effects, including delayed gastric emptying, bowel obstruction, cyclic vomiting syndrome, and even permanent vision loss
Calcium and vitamin D are micronutrients of public health concern for adults in the US, but its always best to speak to your individual doctor or dietitian to find a supplement regimen and dose that is correct for you
That process could push pharmacy access into 2027
No alcohol